# Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

> **NCT00234962** · PHASE4 · TERMINATED · sponsor: **Abbott** · enrollment: 200 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Lopinavir/Ritonavir

## Key facts

- **NCT ID:** NCT00234962
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234962, "Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00234962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*